Published in Carcinogenesis on December 16, 2011
Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives. Curr Pharm Des (2013) 0.91
Attenuation of constitutive DNA damage signaling by 1,25-dihydroxyvitamin D3. Aging (Albany NY) (2012) 0.89
Restoration of the anti-proliferative and anti-migratory effects of 1,25-dihydroxyvitamin D by silibinin in vitamin D-resistant colon cancer cells. Cancer Lett (2015) 0.82
Importance of apical membrane delivery of 1,25-dihydroxyvitamin D3 to vitamin D-responsive gene expression in the colon. Am J Physiol Gastrointest Liver Physiol (2012) 0.79
The renin-angiotensin system mediates EGF receptor-vitamin d receptor cross-talk in colitis-associated colon cancer. Clin Cancer Res (2014) 0.77
Targeted delivery of 1,25-dihydroxyvitamin D3 to colon tissue and identification of a major 1,25-dihydroxyvitamin D3 glycoside from Solanumglaucophyllum plant leaves. J Steroid Biochem Mol Biol (2014) 0.77
Regulation of VDR Expression in Apc-Mutant Mice, Human Colon Cancers and Adenomas. Cancer Prev Res (Phila) (2015) 0.77
H19 Overexpression Induces Resistance to 1,25(OH)2D3 by Targeting VDR Through miR-675-5p in Colon Cancer Cells. Neoplasia (2017) 0.75
Constitutively active RAS signaling reduces 1,25 dihydroxyvitamin D-mediated gene transcription in intestinal epithelial cells by reducing vitamin D receptor expression. J Steroid Biochem Mol Biol (2017) 0.75
The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol (2000) 21.15
The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol (2000) 15.78
A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature (1997) 11.15
The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol (2002) 10.59
TGF-beta and epithelial-to-mesenchymal transitions. Oncogene (2005) 10.02
APC mutations occur early during colorectal tumorigenesis. Nature (1992) 9.50
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet (2005) 8.45
Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med (2006) 7.62
Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev (1999) 7.42
The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res (2002) 6.47
Steroid receptor coactivator-1 is a histone acetyltransferase. Nature (1997) 6.15
Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet (2001) 5.09
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol (2009) 5.05
Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst (2007) 4.89
The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol Cell Biol (2001) 4.80
A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res (2010) 4.77
Transcriptional activators direct histone acetyltransferase complexes to nucleosomes. Nature (1998) 4.68
A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell (1999) 4.65
Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J Biol Chem (2003) 4.55
Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature (1999) 4.40
Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases. Proc Natl Acad Sci U S A (2007) 4.20
Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol (2004) 4.15
Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol (2001) 3.44
Vital signs: Colorectal cancer screening, incidence, and mortality--United States, 2002-2010. MMWR Morb Mortal Wkly Rep (2011) 3.38
MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol (2009) 3.29
Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol (1980) 3.25
Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J Biol Chem (2006) 3.15
Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). J Biol Chem (1992) 3.09
Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Endocr Rev (2005) 2.87
Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology (2007) 2.73
Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA (2003) 2.68
A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes Dev (1998) 2.63
1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem (2007) 2.61
Polycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factor. Mol Cell Biol (2008) 2.57
Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo. Clin Cancer Res (2008) 2.36
Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro. Oral Oncol (2001) 2.12
The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat Med (2004) 2.11
Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol (2007) 2.10
A Western-style diet induces benign and malignant neoplasms in the colon of normal C57Bl/6 mice. Carcinogenesis (2001) 1.99
E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations. Hum Mol Genet (2005) 1.95
The molecular basis of vitamin D receptor and beta-catenin crossregulation. Mol Cell (2006) 1.91
Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies. Nutr Cancer (2009) 1.88
Colorectal cancer prevention. J Clin Oncol (2005) 1.86
Nuclear coactivator-62 kDa/Ski-interacting protein is a nuclear matrix-associated coactivator that may couple vitamin D receptor-mediated transcription and RNA splicing. J Biol Chem (2003) 1.80
Expression of VDR and CYP24A1 mRNA in human tumors. Cancer Chemother Pharmacol (2005) 1.78
Macrophage-derived IL-1beta stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3. Oncogene (2009) 1.64
Expression profile of class I histone deacetylases in human cancer tissues. Oncol Rep (2007) 1.62
25-Hydroxyvitamin D(3)-1alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids (2001) 1.61
Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer. Carcinogenesis (2008) 1.60
Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: a randomized, double-blind, placebo-controlled clinical trial. Cancer Prev Res (Phila) (2009) 1.59
Dietary induction of colonic tumors in a mouse model of sporadic colon cancer. Cancer Res (2008) 1.58
HDACs and HDAC inhibitors in colon cancer. Epigenetics (2008) 1.58
Steroid receptor induction of gene transcription: a two-step model. Proc Natl Acad Sci U S A (1997) 1.50
MicroRNA regulates human vitamin D receptor. Int J Cancer (2009) 1.43
Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice. Immunology (2006) 1.43
Vitamin D receptor is essential for normal keratinocyte stem cell function. Proc Natl Acad Sci U S A (2007) 1.42
Genome-wide analysis of the VDR/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormone. J Steroid Biochem Mol Biol (2010) 1.36
Retracted Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO J (2004) 1.35
Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype. Breast Cancer Res (2008) 1.35
Sequential recruitment of steroid receptor coactivator-1 (SRC-1) and p300 enhances progesterone receptor-dependent initiation and reinitiation of transcription from chromatin. Proc Natl Acad Sci U S A (2001) 1.33
Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription. Proc Natl Acad Sci U S A (1995) 1.33
The candidate oncogene CYP24A1: A potential biomarker for colorectal tumorigenesis. J Histochem Cytochem (2009) 1.30
HDAC3 overexpression and colon cancer cell proliferation and differentiation. Mol Carcinog (2008) 1.29
A new beta-catenin-dependent activation domain in T cell factor. J Biol Chem (2003) 1.29
Identification of a specific binding protein for 1 alpha,25-dihydroxyvitamin D3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia. J Biol Chem (1994) 1.26
Expression of vitamin D receptor and 25-hydroxyvitamin D3-1{alpha}-hydroxylase in normal and malignant human colon. Cancer Epidemiol Biomarkers Prev (2005) 1.25
Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition Cohort (United States). Cancer Causes Control (2003) 1.24
The vitamin D receptor interacts with general transcription factor IIB. J Biol Chem (1995) 1.23
Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling. Proc Natl Acad Sci U S A (2004) 1.20
Snail2 cooperates with Snail1 in the repression of vitamin D receptor in colon cancer. Carcinogenesis (2009) 1.20
Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. Mol Endocrinol (1997) 1.19
Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. Anticancer Res (2008) 1.19
Dietary calcium and vitamin D modulate 1,2-dimethylhydrazine-induced colonic carcinogenesis in the rat. Cancer Res (1991) 1.18
Colorectal cancer screening. Curr Oncol Rep (2009) 1.17
25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression. Biochem Biophys Res Commun (2001) 1.15
Selective use of multiple vitamin D response elements underlies the 1 alpha,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene. Nucleic Acids Res (2007) 1.14
HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signaling. Cancer Biol Ther (2008) 1.13
Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3. Carcinogenesis (1988) 1.12
Effects of vitamin d and calcium on proliferation and differentiation in normal colon mucosa: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2009) 1.12
Diet and cancer: the disconnect between epidemiology and randomized clinical trials. Cancer Epidemiol Biomarkers Prev (2005) 1.10
Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer. Mol Carcinog (2006) 1.10
Vitamin D receptor interaction with specific DNA. Association as a 1,25-dihydroxyvitamin D3-modulated heterodimer. J Biol Chem (1991) 1.10
Vitamin D receptor expression is associated with colon cancer in ulcerative colitis. Oncol Rep (2009) 1.08
1alpha,25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load in the Apc(min) Mouse. Cancer Res (2002) 1.08
The association of calcium and vitamin D with risk of colorectal adenomas. J Nutr (2005) 1.07
1,25-dihydroxyvitamin D3 receptors in normal and malignant human colorectal tissues. Cancer Lett (1994) 1.06
Chemoprevention of colorectal cancer with cyclooxygenase-2 inhibitors: two steps forward, one step back. Lancet Oncol (2007) 1.05
SNAI1 expression in colon cancer related with CDH1 and VDR downregulation in normal adjacent tissue. Oncogene (2009) 1.05
Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence. Cancer Res (2010) 1.04
CYP24A1 inhibition enhances the antitumor activity of calcitriol. Endocrinology (2010) 1.04
Ski-interacting protein, a bifunctional nuclear receptor coregulator that interacts with N-CoR/SMRT and p300. Biochem Biophys Res Commun (2004) 1.04
Epigenetic modulation of the retinoid X receptor alpha by green tea in the azoxymethane-Apc Min/+ mouse model of intestinal cancer. Mol Carcinog (2009) 1.03
Role of nuclear factor kappa B and reactive oxygen species in the tumor necrosis factor-alpha-induced epithelial-mesenchymal transition of MCF-7 cells. Braz J Med Biol Res (2007) 1.03
CYP27A1 and CYP24 expression as a function of malignant transformation in the colon. J Histochem Cytochem (2007) 1.03
DNA methylation-related vitamin D receptor insensitivity in breast cancer. Cancer Biol Ther (2010) 1.02
Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid. Cancer Res (1996) 1.02
Vitamin D receptor and cytokeratin expression may be progression indicators in human colon cancer. Anticancer Res (1996) 1.02
Dietary calcium and vitamin D intake and risk of colorectal cancer: a prospective cohort study in women. Nutr Cancer (2002) 1.01
Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A (2005) 3.64
Rho Family GTPase modification and dependence on CAAX motif-signaled posttranslational modification. J Biol Chem (2008) 2.22
APC-dependent suppression of colon carcinogenesis by PPARgamma. Proc Natl Acad Sci U S A (2002) 1.89
Preliminary analysis of azoxymethane induced colon tumors in inbred mice commonly used as transgenic/knockout progenitors. Int J Oncol (2003) 1.60
Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis. Cancer Res (2008) 1.54
Planar spindle orientation and asymmetric cytokinesis in the mouse small intestine. J Histochem Cytochem (2007) 1.37
HDAC3 overexpression and colon cancer cell proliferation and differentiation. Mol Carcinog (2008) 1.29
Multifaceted roles of PGE2 in inflammation and cancer. Semin Immunopathol (2012) 1.29
Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression. Cancer Res (2006) 1.26
The p50-p50 NF-kappaB complex as a stimulus-specific repressor of gene activation. Mol Cell Biochem (2004) 1.23
Global and specific transcriptional repression by the histone H3 amino terminus in yeast. Proc Natl Acad Sci U S A (2003) 1.23
Roles of cPLA2alpha and arachidonic acid in cancer. Biochim Biophys Acta (2006) 1.19
Genome-wide analysis of the relationship between transcriptional regulation by Rpd3p and the histone H3 and H4 amino termini in budding yeast. Mol Cell Biol (2004) 1.14
HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signaling. Cancer Biol Ther (2008) 1.13
Carcinogen-induced colon tumors in mice are chromosomally stable and are characterized by low-level microsatellite instability. Oncogene (2004) 1.08
mPGES-1 as a target for cancer suppression: A comprehensive invited review "Phospholipase A2 and lipid mediators". Biochimie (2010) 1.07
Deoxycholic acid promotes the growth of colonic aberrant crypt foci. Mol Carcinog (2007) 1.06
Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer. Cancer Res (2004) 1.04
Anti-inflammatory effects of freeze-dried black raspberry powder in ulcerative colitis. Carcinogenesis (2010) 1.04
Selective PGE(2) suppression inhibits colon carcinogenesis and modifies local mucosal immunity. Cancer Prev Res (Phila) (2011) 1.03
Role of Notch signaling in colon homeostasis and carcinogenesis. Cancer Sci (2011) 1.02
Intestinal lineage commitment of embryonic stem cells. Differentiation (2010) 1.01
Ibuprofen inhibits activation of nuclear {beta}-catenin in human colon adenomas and induces the phosphorylation of GSK-3{beta}. Cancer Prev Res (Phila) (2011) 1.00
Microgenomics: Identification of new expression profiles via small and single-cell sample analyses. Cytometry A (2004) 0.99
Aberrant crypt foci in patients with a positive family history of sporadic colorectal cancer. Cancer Lett (2006) 0.98
The transforming Rho family GTPase Wrch-1 disrupts epithelial cell tight junctions and epithelial morphogenesis. Mol Cell Biol (2008) 0.98
Transgenic expression of cyclooxygenase-2 in mouse intestine epithelium is insufficient to initiate tumorigenesis but promotes tumor progression. Cancer Lett (2008) 0.97
Cytoplasmic phospholipase A2 deletion enhances colon tumorigenesis. Cancer Res (2005) 0.96
Inverse association between phospholipase A2 and COX-2 expression during mouse colon tumorigenesis. Carcinogenesis (2003) 0.95
Epidemiology of colonic aberrant crypt foci: review and analysis of existing studies. Cancer Lett (2006) 0.95
Aberrant crypt foci as predictors of colorectal neoplasia on repeat colonoscopy. Cancer Causes Control (2011) 0.93
CD13 is dispensable for normal hematopoiesis and myeloid cell functions in the mouse. J Leukoc Biol (2010) 0.93
Epigenetic alterations in RASSF1A in human aberrant crypt foci. Carcinogenesis (2006) 0.92
Expression of secretory phospholipase A2 in colon tumor cells potentiates tumor growth. Mol Carcinog (2007) 0.91
Suppression of colon carcinogenesis by targeting Notch signaling. Carcinogenesis (2013) 0.90
Cyclooxygenase-2 regulation in colon cancer cells: modulation of RNA polymerase II elongation by histone deacetylase inhibitors. J Biol Chem (2005) 0.90
The induction of aberrant crypt foci (ACF) in the colons of rats by trihalomethanes administered in the drinking water. Cancer Lett (2002) 0.89
Microsatellite instability in aberrant crypt foci from patients without concurrent colon cancer. Carcinogenesis (2006) 0.89
Pharmacological inhibition of Mdm2 triggers growth arrest and promotes DNA breakage in mouse colon tumors and human colon cancer cells. Mol Carcinog (2011) 0.89
Molecular alterations associated with sulindac-resistant colon tumors in ApcMin/+ mice. Cancer Prev Res (Phila) (2010) 0.88
Cytoplasmic phospholipase A2 levels correlate with apoptosis in human colon tumorigenesis. Clin Cancer Res (2005) 0.87
Role of the alternating reading frame (P19)-p53 pathway in an in vivo murine colon tumor model. Cancer Res (2002) 0.87
Dietary iron promotes azoxymethane-induced colon tumors in mice. Nutr Cancer (2004) 0.87
Suppression of kinesin expression disrupts adenomatous polyposis coli (APC) localization and affects beta-catenin turnover in young adult mouse colon (YAMC) epithelial cells. Exp Cell Res (2002) 0.85
Increased frequency of serrated aberrant crypt foci among smokers. Am J Gastroenterol (2010) 0.85
Nanoproteomic analysis of extracellular receptor kinase-1/2 post-translational activation in microdissected human hyperplastic colon lesions. Proteomics (2013) 0.84
Utilizing endoscopic technology to reveal real-time proteomic alterations in response to chemoprevention. Proteomics Clin Appl (2007) 0.84
Src-mediated phosphorylation of the tyrosine phosphatase PRL-3 is required for PRL-3 promotion of Rho activation, motility and invasion. PLoS One (2013) 0.83
Genomic profiles of colorectal cancers differ based on patient smoking status. Cancer Genet Cytogenet (2006) 0.83
Genomic instability of human aberrant crypt foci measured by inter-(simple sequence repeat) PCR and array-CGH. Mutat Res (2006) 0.82
The short chain fatty acid butyrate induces promoter demethylation and reactivation of RARbeta2 in colon cancer cells. Nutr Cancer (2008) 0.82
Dietary methyl donor depletion protects against intestinal tumorigenesis in Apc(Min/+) mice. Cancer Prev Res (Phila) (2012) 0.82
Tamoxifen magnifies therapeutic impact of ceramide in human colorectal cancer cells independent of p53. Biochem Pharmacol (2013) 0.82
cPLA2 is protective against COX inhibitor-induced intestinal damage. Toxicol Sci (2010) 0.81
Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors. Mol Carcinog (2003) 0.81
Number of aberrant crypt foci associated with adiposity and IGF1 bioavailability. Cancer Causes Control (2008) 0.80
Azoxymethane-induced pre-adipocyte factor 1 (Pref-1) functions as a differentiation inhibitor in colonic epithelial cells. Carcinogenesis (2004) 0.80
Oxidative damage in colon and mammary tissue of the HFE-knockout mouse. Free Radic Biol Med (2003) 0.80
Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells. Mol Carcinog (2012) 0.80
p53 and its co-activator p300 are inversely regulated in the mouse colon in response to carcinogen. Toxicol Lett (2003) 0.79
Vascular endothelial growth factor and enhanced angiogenesis do not promote metastatic conversion of a newly established azoxymethane-induced colon cancer cell line. Mol Carcinog (2005) 0.79
Circumvention and reactivation of the p53 oncogene checkpoint in mouse colon tumors. Biochem Pharmacol (2006) 0.78
Chlorogenic acid differentially alters hepatic and small intestinal thiol redox status without protecting against azoxymethane-induced colon carcinogenesis in mice. Nutr Cancer (2010) 0.78
The contribution of methotrexate exposure and host factors on transcriptional variance in human liver. Toxicol Sci (2007) 0.78
Comment re: "Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention" and "Aberrant crypt foci in the adenoma prevention with celecoxib trial". Cancer Prev Res (Phila) (2008) 0.78
Strain-specific homeostatic responses during early stages of Azoxymethane-induced colon tumorigenesis in mice. Int J Oncol (2007) 0.77
Genomic instability measurement in the diagnosis of thyroid neoplasms. Head Neck (2002) 0.77
Molecular markers in colorectal cancer. Lancet (2002) 0.75
Gallbladder cancer gene hypermethylation: genetics or environment? Ann Surg Oncol (2003) 0.75
Multistage gene expression profiling in a differentially susceptible mouse colon cancer model. Cancer Lett (2003) 0.75
Murine models of ulcerative colitis. Arch Pharm Res (2003) 0.75
Colorectal cancer. Mutat Res (2010) 0.75